Imatinib for Multiple Sclerosis (MS) Relapses

NCT03674099 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Imatinib Mesylate
DRUG: Methylprednisolone

Sponsor

Tomas Olsson

Collaborators

[object Object]